Key result
COVID-19 is associated with heterogeneous acute, in-hospital, and long-term cardiovascular complications, including myocarditis, acute coronary syndromes, and arrhythmias.
Why the study?
Despite new therapeutic protocols and vaccines, COVID-19 continues to affect healthcare systems, with cardiovascular history influencing prognosis and previous studies reporting heterogeneous cardiac manifestations.
This review highlights the diverse acute, in-hospital, and long-term cardiovascular complications associated with COVID-19 infection.
Answers are grounded in this paper and cite their sources.
Warrants clinical awareness of CV complications in COVID-19; leaves open precise incidence, mechanisms, and targeted interventions.
In the context of new therapeutic protocols and vaccines developed in the past 3 years, coronavirus 2019 (COVID-19) continues to exert an important impact on the healthcare systems worldwide. Age and a history of cardiovascular or respiratory diseases remain relevant in terms of prognosis for all COVID-19 patients, independent of the viral strain, by conveying a worse outcome and increased rates of in-hospital mortality. Previous studies reported heterogenous cardiovascular manifestations in COVID-19 patients from acute myocarditis or myopericarditis, acute coronary syndromes, stress cardiomyopathy, de novo arrhythmias to pulmonary embolism, or in some rare cases, endocarditis. In this review, we assessed the potential acute, in-hospital and long-term cardiac complications in patients diagnosed with COVID-19.
No takes yet. Share an insight, caveat, or question.
Luchian et al. (2023) conducted a review in COVID-19. COVID-19 was evaluated on Acute, in-hospital and long-term cardiac complications. COVID-19 is associated with heterogeneous acute, in-hospital, and long-term cardiovascular complications, including myocarditis, acute coronary syndromes, and arrhythmias.
Synapse has enriched 10 related papers. Consider them for comparative context: